LADX — LadRx Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
FDA puts partial hold on CytRx cancer drug trials
Brief: CytRx says partial clinical hold affecting aldoxorubicin clinical trials
Brief: CytRx Q3 loss per share $0.10
Brief: CytRx to complete enrollment in Aldoxorubicin trial in 2015
Brief: CytRx to present data from global phase 2b clinical trial of aldoxorubicin
Brief: CytRx launches discovery laboratory to develop albumin-binding anti-cancer drug platform
Market Pulse: Alcoa, Chevron, Wal-Mart, Google, Amazon, BP, MasterCard
Market Pulse: Alcoa, Chevron, Wal-Mart, Google, Amazon, BP, MasterCard
Market Pulse: Alcoa, Chevron, Wal-Mart, Google, Amazon, BP, MasterCard
Market Pulse: Chevron, Mastercard, Accuray, Abaxis, Hanger, Solazyme
Market Pulse: Chevron, Mastercard, Accuray, Abaxis, Hanger, Solazyme
Market Pulse: Jos. A. Bank, Apple, Wal-Mart, Yum Brands, CytRx